CCPortal

浏览/检索结果: 共4条,第1-4条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
A versatile biosensing platform coupling CRISPR–Cas12a and aptamers for detection of diverse analytes 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 1
作者:  Zhao X.;  Li S.;  Liu G.;  Wang Z.;  Yang Z.;  Zhang Q.;  Liang M.;  Liu J.;  Li Z.;  Tong Y.;  Zhu G.;  Wang X.;  Jiang L.;  Wang W.;  Tan G.-Y.;  Zhang L.
收藏  |  浏览/下载:25/0  |  提交时间:2021/09/01
Alpha fetoprotein detection  Aptamer  Biosensing platform  Cocaine detection  CRISPR–Cas12a  Diverse analyte  
Mapping anthropogenic emissions in China at 1 km spatial resolution and its application in air quality modeling 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 6
作者:  Zheng B.;  Cheng J.;  Geng G.;  Wang X.;  Li M.;  Shi Q.;  Qi J.;  Lei Y.;  Zhang Q.;  He K.
收藏  |  浏览/下载:41/0  |  提交时间:2021/09/01
Air quality modeling  Anthropogenic emission inventory  High-resolution mapping  
A pig model carrying heterozygous point mutation of NCSTN simulates familial acne inversa and reveals dysregulated cholesterol biosynthesis via the Notch-pAMPK-HMGCR pathway 期刊论文
Science Bulletin, 2021
作者:  Song R.;  Liu K.;  Wang Y.;  Qin G.;  Xiao M.;  Liu Y.;  Yang J.;  Zong R.;  Yan X.;  Zheng Q.;  Zhang H.;  Hou N.;  Yao J.;  Wang X.;  Wang Y.;  Zhao J.;  Zhang X.
收藏  |  浏览/下载:29/0  |  提交时间:2021/09/01
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS) 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 15
作者:  Jia W.;  Ma J.;  Miao H.;  Wang C.;  Wang X.;  Li Q.;  Lu W.;  Yang J.;  Zhang L.;  Yang J.;  Wang G.;  Zhang X.;  Zhang M.;  Sun L.;  Yu X.;  Du J.;  Shi B.;  Xiao C.;  Zhu D.;  Liu H.;  Zhong L.;  Xu C.;  Xu Q.;  Liang G.;  Zhang Y.;  Li G.;  Gu M.;  Liu J.;  Yuan G.;  Yan Z.;  Yan D.;  Ye S.;  Zhang F.;  Ning Z.;  Cao H.;  Pan D.;  Yao H.;  Lu X.;  Ji L.
收藏  |  浏览/下载:39/0  |  提交时间:2021/09/01
Chiglitazar  Glycemic control  Insulin resistance  PPAR pan-agonist  Type 2 diabetes